The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism

Abstract

Secondary hyperparathyroidism (SHPT) is a frequent condition in the presence of chronic kidney disease (CKD). In CKD patients, SHPT is reported to increase both morbidity and mortality, especially cardiovascular. The difficulty in the treatment of SHPT in clinical practice is frequently encountered from a not always adequate conduct of the clinicians and a common non-compliance to the therapy of CKD patients. In this review, the greatest difficulties from clinicians and CKD-patients' point of view in the treatment of SHPT will be addressed, with particular attention to those related to dialysis features, nutritional habits, and medical therapy.

Keywords: Phosphate binders; Calcimimetics; Calcium; Dialysis; Nutrition; Phosphate; Phosphorus; Secondary hyperparathyroidism; Vitamin D; Vitamin D analogs.